GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » BICO Group AB (CHIX:BICOs) » Definitions » Debt-to-Equity

BICO Group AB (CHIX:BICOS) Debt-to-Equity : 0.65 (As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is BICO Group AB Debt-to-Equity?

BICO Group AB's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was kr118 Mil. BICO Group AB's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was kr1,864 Mil. BICO Group AB's Total Stockholders Equity for the quarter that ended in Mar. 2024 was kr3,032 Mil. BICO Group AB's debt to equity for the quarter that ended in Mar. 2024 was 0.65.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for BICO Group AB's Debt-to-Equity or its related term are showing as below:

CHIX:BICOs' s Debt-to-Equity Range Over the Past 10 Years
Min: 0   Med: 0.1   Max: 0.65
Current: 0.65

During the past 8 years, the highest Debt-to-Equity Ratio of BICO Group AB was 0.65. The lowest was 0.00. And the median was 0.10.

CHIX:BICOs's Debt-to-Equity is ranked worse than
79.54% of 699 companies
in the Medical Devices & Instruments industry
Industry Median: 0.21 vs CHIX:BICOs: 0.65

BICO Group AB Debt-to-Equity Historical Data

The historical data trend for BICO Group AB's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BICO Group AB Debt-to-Equity Chart

BICO Group AB Annual Data
Trend Aug16 Aug17 Aug18 Aug19 Aug20 Dec21 Dec22 Dec23
Debt-to-Equity
Get a 7-Day Free Trial - 0.04 0.24 0.27 0.40

BICO Group AB Quarterly Data
Feb19 May19 Aug19 Nov19 Feb20 May20 Aug20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Debt-to-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.28 0.32 0.32 0.40 0.65

Competitive Comparison of BICO Group AB's Debt-to-Equity

For the Medical Devices subindustry, BICO Group AB's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BICO Group AB's Debt-to-Equity Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, BICO Group AB's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where BICO Group AB's Debt-to-Equity falls into.



BICO Group AB Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

BICO Group AB's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as

BICO Group AB's Debt to Equity Ratio for the quarter that ended in Mar. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


BICO Group AB  (CHIX:BICOs) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.


Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.


BICO Group AB Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of BICO Group AB's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


BICO Group AB (CHIX:BICOS) Business Description

Traded in Other Exchanges
Address
Långfilsgatan 9, Gothenburg, SWE, 41277
BICO Group AB is a bio-convergence company. It is divided into three business areas: Bioprinting (CELLINK, MatTek, Visikol, and Nanoscribe), Biosciences (CYTENA, CYTENA Bioprocess Solutions, Dispendix, and Discover Echo), and Bioautomation (SCIENION, CELLENION, and Ginolis).

BICO Group AB (CHIX:BICOS) Headlines

No Headlines